Breaking News

Sensex Rebounds, Nifty Reclaims 9850 Amid Volatility; Infosys Dips 3%

Shares of Laurus Labs rose 3.5 percent in morning trade on the back of completion of USFDA inspection.

The company has completed the US Food and Drug Administration inspection of its API facilities in Units 1 and 3 at Parawada, Visakhapatnam, Andhra Pradesh with two observation which are only procedural in nature.

This is a regular surveillance audit by USFDA, and no data integrity issues were observed in the inspection.

For more information Call us ✆ +91 9111-179961 or Visit Dollar Advisory

No comments